Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07520591) titled 'Valvosoft Outcomes Registry for Real-World Evidence' on April 3.

Study Type: Observational

Primary Sponsor: Cardiawave SA

Condition: Aortic Valve Disease Aortic Stenosis, Severe Aortic Valve Calcification Ultrasound Therapy Heart Failure

Intervention: Device: Valvosoft Treatment

Recruitment Status: Not recruiting

Date of First Enrollment: May 30, 2026

Target Sample Size: 200

Countries of Recruitment: France Germany Netherlands France Germany Netherlands

To know more, visit https://clinicaltrials.gov/study/NCT07520591

Published by HT Digital Content Services with permission from Health Daily Digest....